BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 16989090)

  • 1. Scintillation proximity assay for DNA binding by human p53.
    Gal S; Cook JR; Howells L
    Biotechniques; 2006 Sep; 41(3):303-8. PubMed ID: 16989090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three assays show differences in binding of wild-type and mutant p53 to unique gene sequences.
    Chandrachud U; Gal S
    Technol Cancer Res Treat; 2009 Dec; 8(6):445-53. PubMed ID: 19925028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scintillation proximity assay for total p53 protein as an alternative to ELISA.
    Oberlander S; Xie T; Chandrachud U; Gal S
    J Immunol Methods; 2010 Aug; 360(1-2):173-7. PubMed ID: 20600074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 binds human telomeric G-quadruplex in vitro.
    Adámik M; Kejnovská I; Bažantová P; Petr M; Renčiuk D; Vorlíčková M; Brázdová M
    Biochimie; 2016; 128-129():83-91. PubMed ID: 27422117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of scintillation proximity assay to measure radioligand binding to immobilized receptors without separation of bound from free ligand.
    Berry J; Price-Jones M; Killian B
    Methods Mol Biol; 2012; 897():79-94. PubMed ID: 22674161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. YY1 binding to a subset of p53 DNA-target sites regulates p53-dependent transcription.
    Yakovleva T; Kolesnikova L; Vukojević V; Gileva I; Tan-No K; Austen M; Lüscher B; Ekström TJ; Terenius L; Bakalkin G
    Biochem Biophys Res Commun; 2004 May; 318(2):615-24. PubMed ID: 15120643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Searching for target sequences by p53 protein is influenced by DNA length.
    Brázda V; Jagelská EB; Fojta M; Palecek E
    Biochem Biophys Res Commun; 2006 Mar; 341(2):470-7. PubMed ID: 16426567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A homogeneous method to measure aminoacyl-tRNA synthetase aminoacylation activity using scintillation proximity assay technology.
    Macarrón R; Mensah L; Cid C; Carranza C; Benson N; Pope AJ; Díez E
    Anal Biochem; 2000 Sep; 284(2):183-90. PubMed ID: 10964400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of p56(lck) kinase activity using scintillation proximity assay in 384-well format and imaging proximity assay in 384- and 1536-well format.
    Beveridge M; Park YW; Hermes J; Marenghi A; Brophy G; Santos A
    J Biomol Screen; 2000 Aug; 5(4):205-12. PubMed ID: 10992041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of scintillation proximity assay in drug discovery.
    Wu S; Liu B
    BioDrugs; 2005; 19(6):383-92. PubMed ID: 16392890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FUSE Binding Protein 1 Facilitates Persistent Hepatitis C Virus Replication in Hepatoma Cells by Regulating Tumor Suppressor p53.
    Dixit U; Pandey AK; Liu Z; Kumar S; Neiditch MB; Klein KM; Pandey VN
    J Virol; 2015 Aug; 89(15):7905-21. PubMed ID: 25995247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA modification with cisplatin affects sequence-specific DNA binding of p53 and p73 proteins in a target site-dependent manner.
    Pivonková H; Pecinka P; Cesková P; Fojta M
    FEBS J; 2006 Oct; 273(20):4693-706. PubMed ID: 16981908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a scintiplate assay for recombinant human alpha(2B)-adrenergic receptor.
    Sen S; Jaakola VP; Heimo H; Kivelä P; Scheinin M; Lundstrom K; Goldman A
    Anal Biochem; 2002 Aug; 307(2):280-6. PubMed ID: 12202245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of TP53-DNA interaction induced by p.C135R in lung cancer.
    Aranda M; Gonzalez-Nilo F; Riadi G; Díaz V; Perez J; Martel G; Hainaut P; Mimbacas A
    Oncol Rep; 2007 Nov; 18(5):1213-7. PubMed ID: 17914575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutant p53 proteins bind DNA in a DNA structure-selective mode.
    Göhler T; Jäger S; Warnecke G; Yasuda H; Kim E; Deppert W
    Nucleic Acids Res; 2005; 33(3):1087-100. PubMed ID: 15722483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a high throughput scintillation proximity assay for hepatitis C virus NS3 protease that reduces the proportion of competitive inhibitors identified.
    Fowler A; Price-Jones M; Hughes K; Anson J; Lingham R; Schulman M
    J Biomol Screen; 2000 Jun; 5(3):153-8. PubMed ID: 10894758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scintillation proximity assay (SPA) technology to study biomolecular interactions.
    Cook N; Harris A; Hopkins A; Hughes K
    Curr Protoc Protein Sci; 2002 May; Chapter 19():Unit 19.8. PubMed ID: 18429228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A scintillation proximity assay for human interleukin-5 (hIL-5) high-affinity binding in insect cells coexpressing hIL-5 receptor alpha and beta subunits.
    Zhang J; Wu P; Kuvelkar R; Schwartz JL; Egan RW; Billah MM; Wang P
    Anal Biochem; 1999 Mar; 268(1):134-42. PubMed ID: 10036172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Miniaturization of a hepatitis C virus RNA polymerase assay using a -102 degrees C cooled CCD camera-based imaging system.
    Zheng W; Carroll SS; Inglese J; Graves R; Howells L; Strulovici B
    Anal Biochem; 2001 Mar; 290(2):214-20. PubMed ID: 11237322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA binding and 3'-5' exonuclease activity in the murine alternatively-spliced p53 protein.
    Shakked Z; Yavnilovitch M; Kalb Gilboa AJ; Kessler N; Wolkowicz R; Rotter V; Haran TE
    Oncogene; 2002 Aug; 21(33):5117-26. PubMed ID: 12140762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.